Category: Investor updates

Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to provide an update on its activities

The announcement “Appendix 3Y — Change of Director’s Interest Notice” has been lodged with the Australian Securities Exchange. Read Appendix 3Y — Change of Director’s

Imagion Biosystems has lodged the announcement “Despatch of Rights Issue Offer Documents” with the Australian Securities Exchange. View Despatch of Rights Issue Offer Documents.

Imagion Biosystems has lodged the announcement “Pro-Rata Non-Renounceable Rights Issue” with the Australian Securities Exchange. View the announcement “Pro-Rata Non-Renounceable Rights Issue.”

Imagion Biosystems has lodged Notice to Optionholders — Pro-Rata Non-Renounceable Rights Issue. View the Notice to Optionholders.

Imagion Biosystems has lodged Pro-Rata Non-Renounceable Rights Issue: Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth) with the Australian Securities Exchange. View the Pro-Rata non-Renounceable

Imagion Biosystems has lodged Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. View Appendix 3B.

Imagion Biosystems Limited has lodged a Rights Issue Offer Document with the Australian Securities Exchange. View the Rights Issue Offer Document.

The suspension of trading in the securities of Imagion Biosystems Limited (‘IBX’) will be lifted immediately, following the release by IBX of an announcement regarding

Imagion Biosystems Limited (ASX: IBX) (Imagion or the Company) is pleased to announce a pro-rata non- renounceable rights issue (Offer) to shareholders, on the basis